AIM ImmunoTech and Shenzhen Smoore Technology Announce an Agreement to Research Utilizing an Innovative Smoore Inhalation Delivery Device and Ampligen (rintatolimod) as a Potential, Easy-To-Use Treatment Approach for the SARS-CoV-2 Pandemic
OCALA, FL / ACCESSWIRE / April 6, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced it has entered into a...